ChemBriefSouth Africa's Aspen Pharmacare to Sell Women's Health Product in Europe to Ennogen
South Africa's Aspen Pharmacare sold European commercialization rights for its women's health product Ovestin to Ennogen Healthcare International for €197 million. Under the deal, Aspen will maintain
reuters · 2026-11-02 04:53